Ingevity Co. (NYSE:NGVT) Shares Sold by Schechter Investment Advisors LLC

Schechter Investment Advisors LLC trimmed its position in Ingevity Co. (NYSE:NGVT) by 20.4% during the 4th quarter, Holdings Channel.com reports. The fund owned 19,432 shares of the company’s stock after selling 4,978 shares during the period. Schechter Investment Advisors LLC’s holdings in Ingevity were worth $918,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently made changes to their positions in the company. Covestor Ltd grew its position in Ingevity by 26,850.0% during the 2nd quarter. Covestor Ltd now owns 539 shares of the company’s stock worth $31,000 after purchasing an additional 537 shares during the period. FMR LLC boosted its stake in shares of Ingevity by 15.7% during the 3rd quarter. FMR LLC now owns 2,394 shares of the company’s stock worth $114,000 after acquiring an additional 324 shares in the last quarter. Rockefeller Capital Management L.P. boosted its stake in shares of Ingevity by 936.4% during the 1st quarter. Rockefeller Capital Management L.P. now owns 2,933 shares of the company’s stock worth $209,000 after acquiring an additional 2,650 shares in the last quarter. Pathstone Family Office LLC boosted its stake in shares of Ingevity by 22.1% during the 3rd quarter. Pathstone Family Office LLC now owns 4,430 shares of the company’s stock worth $211,000 after acquiring an additional 803 shares in the last quarter. Finally, Mariner LLC purchased a new stake in shares of Ingevity during the 4th quarter worth about $224,000. 91.59% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Separately, Wells Fargo & Company increased their target price on shares of Ingevity from $43.00 to $50.00 and gave the stock an “equal weight” rating in a research note on Friday, February 23rd. Five investment analysts have rated the stock with a hold rating, Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $48.75.

Ingevity Price Performance

NGVT stock opened at $48.44 on Thursday. The business’s 50-day moving average is $45.39 and its 200 day moving average is $43.82. Ingevity Co. has a 12-month low of $36.66 and a 12-month high of $74.74. The company has a current ratio of 1.81, a quick ratio of 0.96 and a debt-to-equity ratio of 2.19.

Ingevity (NYSE:NGVT) last issued its earnings results on Wednesday, February 21st. The company reported $0.21 earnings per share for the quarter, topping the consensus estimate of ($0.13) by $0.34. The business had revenue of $371.70 million for the quarter, compared to analysts’ expectations of $336.74 million. Ingevity had a positive return on equity of 20.75% and a negative net margin of 0.32%. The business’s revenue for the quarter was down 3.1% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.57 EPS. As a group, equities analysts expect that Ingevity Co. will post 3.65 earnings per share for the current fiscal year.

Ingevity Company Profile

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.